drugset / Trial / NCT06506591
A Single-And Multiple-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of WD-890 Tablets in Healthy Chinese Subjects
RandomizedSequentialDouble-blindOther
Summary
This is a phase I, randomised, double-blind, placebo-controlled, 3-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of WD-890 Tablets in Healthy Chinese Subjects
Timeline
- Start
- 2023-10-26
- Primary completion
- 2024-08-15
- Completion
- 2024-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WD-890 | Unknown | 1 mg | Oral |
| Subject | WD-890 | Unknown | 3 mg | Oral |
| Subject | WD-890 | Unknown | 6 mg | Oral |
| Subject | WD-890 | Unknown | 9 mg | Oral |
Indications
No indication recorded.